Advertisement

Topics

Prana Biotechnology Limited Company Profile

06:13 EST 22nd November 2017 | BioPortfolio

Prana Biotechnology was established to commercialise research into Alzheimer's disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the Australian Stock Exchange in March 2000 and listed on NASDAQ in September 2002. Researchers at prominent international institutions including The University of Melbourne, The Mental Health Research Institute (Melbourne) and Massachusetts General Hospital, a teaching hospital of Harvard Medical School, contributed to the discovery of Prana's technology.


News Articles [158 Associated News Articles listed on BioPortfolio]

Prana Biotechnology (PRAN) vs. Foundation Medicine (FMI) Head-To-Head Survey

Prana Biotechnology and Foundation Medicine are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional...

Prana pairs up with Takeda in Parkinson’s gastrointestinal neuropathology

Australia’s Prana Biotechnology was trading 6% higher at $2.80 late morning on Tuesday after the announcement…

Prana Biotechnology Ltd (PRAN) Upgraded to Sell by ValuEngine

Shares of Prana Biotechnology traded up 5.85% during trading on Friday, hitting $3.44. The stock had a trading volume of 555,616 shares.

Prana partners with Takeda in Parkinson’s gastrointestinal neuropathology

Prana Biotechnology has entered into a research collaboration with Takeda Pharmaceuticals International to study the potential of its investigational movement disorders compound, PBT434, to slow or pr...

Takeda and Prana to research neurodegeneration treatment for Parkinson's disease

Takeda Pharmaceuticals International has entered a new research collaboration to study the ability of Prana Biotechnology’s investigational movement disorders compound, PBT434, to slow down or preve...

Prana Biotech +15% on favorable PBT434 pre-clinical results

Prana Biotechnology jumps as much as 25% after disclosing that the article "The novel compound PBT434 prevents iron-mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkin...

Prana Commences Research Collaboration with Takeda for the Treatment of Parkinson's Disease ...

PBT434, Prana’s lead drug in preclinical development for movement disorders, to be profiled in collaborative venture Read more...

Professor Ira Shoulson, Georgetown University & Prana Biotechnology

Professor Ira Shoulson, Georgetown University & Prana Biotechnology

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

Liprotamase powder is a non-porcine, soluble and stable mixture of biotechnology-derived lipase, protease, and amylase digestive enzymes. The purpose of the present study is to to evaluate...

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

This study will be a Phase I, randomized, double blind, safety and immunogenicity trial of the Vero cell based 116E neonatal rotavirus vaccine candidate strain in healthy non-malnourished ...

Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age

Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clinical syndromes.Primary infection is manifested as varicella (chickenpox), whereas reactivation of latent VZV resu...

Companies [941 Associated Companies listed on BioPortfolio]

Prana Biotechnology Limited

Prana Biotechnology was established to commercialise research into Alzheimer's disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the A...

Prana Biotechnology

Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease ...

Prana Biotechnology Ltd

Prana

Nil

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

More Information about "Prana Biotechnology Limited" on BioPortfolio

We have published hundreds of Prana Biotechnology Limited news stories on BioPortfolio along with dozens of Prana Biotechnology Limited Clinical Trials and PubMed Articles about Prana Biotechnology Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prana Biotechnology Limited Companies in our database. You can also find out about relevant Prana Biotechnology Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...


Corporate Database Quicklinks



Searches Linking to this Company Record